Healthcare Services

Introduction of advanced implantable devices is shaping the liver cirrhosis market

April 23, 2026April 23, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Forecasted Market Size Trajectory Of The Liver Cirrhosis Market From 2026 To 2030?

The market for liver cirrhosis has experienced substantial growth over recent years. Projections indicate it will expand from $1.99 billion in 2025 to $2.15 billion in 2026, registering a compound annual growth rate (CAGR) of 7.8%. Historically, this growth is primarily due to factors such as chronic alcohol consumption patterns, widespread hepatitis b and c infections, limited early detection of liver damage, a rising incidence of fatty liver disease, and a historical lack of curative treatment options.

The market size for liver cirrhosis is anticipated to experience robust growth in the upcoming years. It is projected to expand to $2.88 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.7%. This expansion during the forecast period is attributable to the increasing burden of NASH and metabolic syndrome, rising awareness of liver health, broader access to diagnostic testing, a growing demand for advanced liver care, and increased healthcare spending on chronic diseases. Prominent trends for the forecast period encompass the rising prevalence of chronic liver diseases, an intensified focus on early diagnosis and disease monitoring, an increasing need for long-term disease management, the expansion of supportive and symptom-based therapies, and a growing requirement for specialized hepatology care.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=22040&type=smp

What Major Factors Are Driving The Liver Cirrhosis Market Forward?

The anticipated rise in alcohol intake is projected to fuel the expansion of the liver cirrhosis market in the coming period. Alcohol consumption denotes the ingestion of alcoholic drinks, usually quantified by amount and regularity. Individuals are progressively consuming alcohol as it aids in relieving everyday stress, facilitates social bonds at events, and improves leisure moments, alongside its extensive media promotion and increased availability across diverse environments. Treating liver cirrhosis in individuals with excessive alcohol intake involves managing hepatic injury via sobriety, pharmacological interventions, and supportive measures, concurrently tackling alcohol addiction through therapy and recovery programs. As an illustration, in December 2024, data from the Bureau of Labor Statistics, a US-based governmental body, revealed that in 2023, the typical U.S. household allocated an average of $294 for alcoholic drinks consumed within the home and $343 for those consumed away from home. Consequently, the growing intake of alcohol stimulates the liver cirrhosis market.

What Are The Main Segments Within The Liver Cirrhosis Market Segment Structure?

The liver cirrhosis market covered in this report is segmented –

1) By Type: Alcoholic Cirrhosis, Biliary Cirrhosis, Cardiac Cirrhosis, Cryptogenic Cirrhosis

2) By Treatment: Antibiotics, Immunosuppressants, Other Treatments

3) By End Users: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Academic And Research Institutes, Other End Users

Subsegments:

1) By Alcoholic Cirrhosis: Compensated Alcoholic Cirrhosis, Decompensated Alcoholic Cirrhosis, Alcoholic Steatohepatitis (ASH)-Associated Cirrhosis

2) By Biliary Cirrhosis: Primary Biliary Cirrhosis (PBC), Secondary Biliary Cirrhosis, Autoimmune Biliary Cirrhosis

3) By Cardiac Cirrhosis: Right Heart Failure-Induced Cirrhosis, Chronic Passive Congestion Cirrhosis, Ischemic Hepatitis Cirrhosis

4) By Cryptogenic Cirrhosis: Non-Alcoholic Steatohepatitis (NASH)-Associated Cirrhosis, Idiopathic Cirrhosis, Metabolic Syndrome-Associated Cirrhosis

Which Trends Are Impacting The Progress Of The Liver Cirrhosis Market?

Leading companies within the liver cirrhosis market are concentrating on advancements in treatment solutions, such as the creation of active implantable medical devices, to enhance patient outcomes and broaden therapeutic potential. Active implantable medical devices are electronically powered implants intended to monitor, support, or improve organ functionality inside the body. For instance, in December 2024, Sequana Medical NV, a medical device company based in Belgium, secured U.S. FDA approval for its alfapump system, marking it as the first active implantable medical device in the U.S. for managing recurrent or refractory ascites resulting from liver cirrhosis. This groundbreaking technology offers a continuous, automated approach to fluid management by relocating surplus abdominal fluid to the bladder, considerably lessening the need for invasive therapeutic paracentesis. The alfapump represents a significant step forward in improving patient outcomes and enhancing quality of life for an addressable market of approximately 70,000 patients in the United States.

Who Are The Companies Participating In The Liver Cirrhosis Market?

Major companies operating in the liver cirrhosis market are F Hoffmann-La Roche Ltd., Abbott Laboratories, Thermo Fisher Scientific Inc., Siemens Healthineers AG, GE HealthCare Technologies Inc., Fujifilm Holdings Corporation, Canon Medical Systems Corporation, Koninklijke Philips N.V., Samsung Medison Co. Ltd., Mindray Medical International Limited, Boston Scientific Corporation, Olympus Corporation, Echosens SA, Hologic Inc., Beckman Coulter Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., bioMérieux SA, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Perspectum Diagnostics Ltd., Owlstone Medical Ltd.

Get The Full Liver Cirrhosis Market Report:

https://www.thebusinessresearchcompany.com/report/liver-cirrhosis-global-market-report

Where Is The Liver Cirrhosis Market Most Concentrated Geographically?

North America was the largest region in the liver cirrhosis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the liver cirrhosis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Liver Cirrhosis Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/liver-cirrhosis-global-market-report

Browse Through More Reports Similar to the Global Liver Cirrhosis Market 2026, By The Business Research Company

Liver Health Supplements Market Report 2026

https://www.thebusinessresearchcompany.com/report/liver-health-supplements-global-market-report

Liver Cancer Diagnostics Market Report

https://www.thebusinessresearchcompany.com/report/liver-cancer-diagnostics-global-market-report

Hepatic Encephalopathy Market Report

https://www.thebusinessresearchcompany.com/report/hepatic-encephalopathy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795